BRIEF-Black Diamond Therapeutics Announces Restructuring Plan To Focus Resources On Bdtx-1535 And Extend Cash Runway

Reuters
08 Oct 2024

Black Diamond Therapeutics Inc :

* BLACK DIAMOND THERAPEUTICS ANNOUNCES RESTRUCTURING PLAN TO FOCUS RESOURCES ON BDTX-1535 AND EXTEND CASH RUNWAY

* BLACK DIAMOND THERAPEUTICS INC - WILL DEPRIORITIZE BDTX-4933 AND SEEK POTENTIAL PARTNERS

* BLACK DIAMOND THERAPEUTICS INC - COST SAVINGS EXPECTED TO EXTEND CASH RUNWAY INTO Q2 2026

* BLACK DIAMOND THERAPEUTICS INC - RESTRUCTURING EXPECTED TO FUND OPERATIONS INTO Q2 2026

* BLACK DIAMOND THERAPEUTICS - BLACK DIAMOND IS ACTIVELY SEEKING PARTNERSHIPS AS IT DEPRIORITIZES ITS BDTX-4933 PROGRAM IN RAF/RAS-MUTANT SOLID TUMORS

* BLACK DIAMOND THERAPEUTICS INC - CFO FANG NI AND CPO ELIZABETH MONTGOMERY DEPARTING BLACK DIAMOND

* BLACK DIAMOND THERAPEUTICS- TO ENABLE FOCUSED INVESTMENT IN BDTX-1535, TAKEN STEPS TO OPTIMIZE OPERATIONS, INCLUDING A REDUCTION IN FORCE

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10